Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | — | — |
Vaccine mix up/patient received Bexsero and Menveo instaed of Bexsero and gardasil; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included HPV vaccine VLP rL1 4v (yeast) (Gardasil) for prophylaxis. Previously administered products included Menveo (1st dose received on 19-AUG-2024 with batch number 77428, expiry date-31-jan-2027). On 24-SEP-2025, the patient received the 2nd dose of Menveo. On an unknown date, the patient received Gardasil. On 24-SEP-2025, an unknown time after receiving Menveo and an unknown time after receiving Gardasil, the patient experienced wrong vaccine administered (Verbatim: Vaccine mix up/patient received Bexsero and Menveo instaed of Bexsero and gardasil). The outcome of the wrong vaccine administered was not applicable. Additional Information: GSK Receipt Date: 25-SEP-2025 Practice manager reported that a patient received Bexsero and Menveo instead of Bexsero and Gardasil. This was the patient's 2nd dose of Menveo. The reporter consented to follow up.